Nicholas Grund
First SEC filing: Feb. 4, 2025 · Latest: Feb. 4, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | AKBA | S 10b5-1 | 53,585 | $1.39 | $74,483 | 592,994 Direct | -8.29% | Disposed | -37.8% (price as of 2026-10-02) |
| Feb. 2, 2026 | AKBA | S 10b5-1 | 31,244 | $1.39 | $43,429 | 561,750 Direct | -5.27% | Disposed | -37.8% (price as of 2026-10-02) |
| Jan. 30, 2026 | AKBA | A | 204,000 | · | · | 646,579 Direct | +46.09% | Acquired | (price as of 2026-10-02) |
| Jan. 30, 2026 | AKBA | A | 320,000 | · | · | 320,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 3, 2025 | AKBA | S 10b5-1 | 55,621 | $2.10 | $116,804 | 442,579 Direct | -11.16% | Disposed | -58.8% (price as of 2026-10-02) |
| Jan. 31, 2025 | AKBA | A | 194,900 | · | · | 498,200 Direct | +64.26% | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2025 | AKBA | A | 292,300 | · | · | 292,300 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2024 | AKBA | A | 303,300 | · | · | 303,300 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2024 | AKBA | A | 454,950 | · | · | 454,950 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | AKBA | Stock Option (Right to buy) | Common Stock | $1.41 | Jan. 30, 2036 | 320,000 | Acquired |
| Jan. 31, 2025 | AKBA | Stock Option (Right to buy) | Common Stock | $2.24 | Jan. 31, 2035 | 292,300 | Acquired |
| Jan. 31, 2024 | AKBA | Stock Option (Right to buy) | Common Stock | $1.68 | Jan. 31, 2034 | 454,950 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $506,742 | · | · | · | $204,672 | · | $17,500 | $1,728,405 |
| 2024 | $459,393 | · | · | · | $206,384 | · | $18,447 | $1,854,631 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.